Vetera 2XP (Canada)This page contains information on Vetera 2XP for veterinary use.
The information provided typically includes the following:
- Vetera 2XP Indications
- Warnings and cautions for Vetera 2XP
- Direction and dosage information for Vetera 2XP
Vetera 2XPThis treatment applies to the following species:
Equine Rhinopneumonitis-Influenza Vaccine
Veterinary Use Only
Vetera 2XP Indications
For vaccination of healthy horses 4 months of age or older, including pregnant mares, as an aid in reduction of respiratory diseases caused by Equine Herpesvirus types 1 and 4 (EHV-1 and EHV-4); and as an aid in the reduction of respiratory disease and shedding caused by A2 Equine Influenza virus. Product contains Kentucky Lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) equine influenza strains. Efficacy (DOI) has been demonstrated for at least 6 months against OH/03.
Administration and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.
PrecautionsStore at 2-7°C. Do not freeze. Do not vaccinate within 21 days before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.
Preservatives: Gentamicin and Amphotericin B.
Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.
Manufactured by: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.S.A.
US Vet. Lic. No. 124
Manufactured for: Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario L7L 5H4
10 Doses/10 mL
5180 SOUTH SERVICE ROAD, BURLINGTON, ON, L7L 5H4
|Customer Care No.:||1-800-567-1885|
|Technical Services No.:||1-877-565-5501|
Copyright © 2023 Animalytix LLC. Updated: 2023-05-29